Skip to main content
. 2014 Jun 20;64(4):636–645. doi: 10.1136/gutjnl-2013-306620

Figure 4.

Figure 4

Signalling pathways genetically altered in CRC. (A) Significantly mutated pathways with positive selection of non-silent mutations were ranked by Q-score. (B) Mutation frequencies of individual signalling components of four major signalling pathways, namely, Wnt signalling, ErbB signalling, transforming growth factor-β signalling and DNA damage sensing/repair, in 182 patients with CRC were shown. These pathways exhibited genetic alteration in a majority (50–65%) of CRC samples.